1h
WMFS Radio Memphis on MSN(J&J Tigers AUDIO): Penny on Naismith Coach of Year Watch ListHardaway Named to Werner Ladder Naismith Men's College Coach of the Year Watch List Jason and John interview ESPN Analyst ...
The Bears/Khalil Mack edge rusher rumor mill is churning again from people who treat fact loosely, but GM Ryan Poles really ...
Cameco Corporation (NYSE: CCJ) stock, which initially seemed to be moving higher after reporting 2024 earnings yesterday, ended up losing a penny's-worth of stock price. The selling is getting even ...
Heather Evans Smith's exhibit "Blue" explores personal grief and mental health through photography, symbolizing depression ...
We know it's Flagg vs. Broome right now for NPOY. But who's the best backcourt performer in college hoops right now?
Penny Hardaway admits there have been plenty of times he made things hard for himself as Memphis basketball coach. Now he is ...
Here we highlight a subset of our preferred stocks from the screener. Overview: Entera Bio Ltd. is a clinical-stage company developing oral peptide or protein replacement therapies for unmet ...
Play the USA TODAY Daily Crossword Puzzle ... clogging up passing and dribbling lanes with the presence of Penny and Clawson-Smith constantly around the basketball. Baker led the Mavericks ...
James Wiseman, part of Penny Hardaway's first No. 1 recruiting class, traded to Raptors, then waived
James Wiseman — who played for Penny Hardaway in high school and was a member of Memphis basketball's No. 1 recruiting class in 2019 — was traded by the Indiana Pacers to the Toronto ...
Need a break? Play the USA TODAY Daily Crossword Puzzle. Lerner said one highlight of the exhibition will be a collection of African-inspired masks Smith created using found objects. "He was a ...
It wasn't part of his normal routine, but Memphis basketball coach Penny Hardaway made time on Wednesday to pull his star player aside before the game. PJ Haggerty, in the midst of an All-American ...
Overview: Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company in the U.S. focused on developing antibody-based therapeutics for oncology, with a market cap of $429.28 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results